Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > ALPK2(Gene name) > Human
  • Add your favorite
  • ALPK2 (Gene name),
  • Alpha-protein kinase 2 (Protein name ),  ALPK2_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    ALPK2(HAK);
    Protein name:
    Alpha-protein kinase 2;
    Alternative:
    Heart alpha-protein kinase;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    N/A
    Function:
    Kinases that recognize phosphorylation sites in which the surrounding peptides have an alpha-helical conformation.
    Subcellular Location:
    N/A
    Protein Attributes:
    Sequence length:
    2170
    Sequence:
    50:
    MKDSEGPQRP | PLCFLSTLLS | QKVPEKSDAV | LRCIISGQPK | PEVTWYKNGQ | 
    100:
    AIDGSGIISN | YEFFENQYIH | VLHLSCCTKN | DAAVYQISAK | NSFGMICCSA | 
    150:
    SVEVECSSEN | PQLSPNLEDD | RDRGWKHETG | THEEERANQI | DEKEHPYKEE | 
    200:
    ESISPGTPRS | ADSSPSKSNH | SLSLQSLGNL | DISVSSSENP | LGVKGTRHTG | 
    250:
    EAYDPSNTEE | IANGLLFLNS | SHIYEKQDRC | CHKTVHSMAS | KFTDGDLNND | 
    300:
    GPHDEGLRSS | QQNPKVQKYI | SFSLPLSEAT | AHIYPGDSAV | ANKQPSPQLS | 
    350:
    SEDSDSDYEL | CPEITLTYTE | EFSDDDLEYL | ECSDVMTDYS | NAVWQRNLLG | 
    400:
    TEHVFLLESD | DEEMEFGEHC | LGGCEHFLSG | MGCGSRVSGD | AGPMVATAGF | 
    450:
    CGHHSQPQEV | GVRSSRVSKH | GPSSPQTGMT | LILGPHQDGT | SSVTEQGRYK | 
    500:
    LPTAPEAAEN | DYPGIQGETR | DSHQAREEFA | SDNLLNMDES | VRETEMKLLS | 
    550:
    GESENSGMSQ | CWETAADKRV | GGKDLWSKRG | SRKSARVRQP | GMKGNPKKPN | 
    600:
    ANLRESTTEG | TLHLCSAKES | AEPPLTQSDK | RETSHTTAAA | TGRSSHADAR | 
    650:
    ECAISTQAEQ | EAKTLQTSTD | SVSKEGNTNC | KGEGMQVNTL | FETSQVPDWS | 
    700:
    DPPQVQVQET | VRETISCSQM | PAFSEPAGEE | SPFTGTTTIS | FSNLGGVHKE | 
    750:
    NASLAQHSEV | KPCTCGPQHE | EKQDRDGNIP | DNFREDLKYE | QSISEANDET | 
    800:
    MSPGVFSRHL | PKDARADFRE | PVAVSVASPE | PTDTALTLEN | VCDEPRDREA | 
    850:
    VCAMECFEAG | DQGTCFDTID | SLVGRPVDKY | SPQEICSVDT | ELAEGQNKVS | 
    900:
    DLCSSNDKTL | EVFFQTQVSE | TSVSTCKSSK | DGNSVMSPLF | TSTFTLNISH | 
    950:
    TASEGATGEN | LAKVENSTYP | LASTVHAGQE | QPSPSNSGGL | DETQLLSSEN | 
    1000:
    NPLVQFKEGG | DKSPSPSAAD | TTATPASYSS | IVSFPWEKPT | TLTANNECFQ | 
    1050:
    ATRETEDTST | VTIATEVHPA | KYLAVSIPED | KHAGGTEERF | PRASHEKVSQ | 
    1100:
    FPSQVQLDHI | LSGATIKSTK | ELLCRAPSVP | GVPHHVLQLP | EGEGFCSNSP | 
    1150:
    LQVDNLSGDK | SQTVDRADFR | SYEENFQERG | SETKQGVQQQ | SLSQQGSLSA | 
    1200:
    PDFQQSLPTT | SAAQEERNLV | PTAHSPASSR | EGAGQRSGWG | TRVSVVAETA | 
    1250:
    GEEDSQALSN | VPSLSDILLE | ESKEYRPGNW | EAGNKLKIIT | LEASASEIWP | 
    1300:
    PRQLTNSESK | ASDGGLIIPD | KVWAVPDSLK | ADAVVPELAP | SEIAALAHSP | 
    1350:
    EDAESALADS | RESHKGEEPT | ISVHWRSLSS | RGFSQPRLLE | SSVDPVDEKE | 
    1400:
    LSVTDSLSAA | SETGGKENVN | NVSQDQEEKQ | LKMDHTAFFK | KFLTCPKILE | 
    1450:
    SSVDPIDEIS | VIEYTRAGKP | EPSETTPQGA | REGGQSNDGN | MGHEAEIQPA | 
    1500:
    ILQVPCLQGT | ILSENRISRS | QEGSMKQEAE | QIQPEEAKTA | IWQVLQPSEG | 
    1550:
    GERIPSGCSI | GQIQESSDGS | LGEAEQSKKD | KAELISPTSP | LSSCLPIMTH | 
    1600:
    ASLGVDTHNS | TGQIHDVPEN | DIVEPRKRQY | VFPVSQKRGT | IENERGKPLP | 
    1650:
    SSPDLTRFPC | TSSPEGNVTD | FLISHKMEEP | KIEVLQIGET | KPPSSSSSSA | 
    1700:
    KTLAFISGER | ELEKAPKLLQ | DPCQKGTLGC | AKKSREREKS | LEARAGKSPG | 
    1750:
    TLTAVTGSEE | VKRKPEAPGS | GHLAEGVKKK | ILSRVAALRL | KLEEKENIRK | 
    1800:
    NSAFLKKMPK | LETSLSHTEE | KQDPKKPSCK | REGRAPVLLK | KIQAEMFPEH | 
    1850:
    SGNVKLSCQF | AEIHEDSTIC | WTKDSKSIAQ | VQRSAGDNST | VSFAIVQASP | 
    1900:
    KDQGLYYCCI | KNSYGKVTAE | FNLTAEVLKQ | LSSRQDTKGC | EEIEFSQLIF | 
    1950:
    KEDFLHDSYF | GGRLRGQIAT | EELHFGEGVH | RKAFRSTVMH | GLMPVFKPGH | 
    2000:
    ACVLKVHNAI | AYGTRNNDEL | IQRNYKLAAQ | ECYVQNTARY | YAKIYAAEAQ | 
    2050:
    PLEGFGEVPE | IIPIFLIHRP | ENNIPYATVE | EELIGEFVKY | SIRDGKEINF | 
    2100:
    LRRESEAGQK | CCTFQHWVYQ | KTSGCLLVTD | MQGVGMKLTD | VGIATLAKGY | 
    2150:
    KGFKGNCSMT | FIDQFKALHQ | CNKYCKMLGL | KSLQNNNQKQ | KQPSIGKSKV | 
    2170:
    QTNSMTIKKA | GPETPGEKKT | 
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    Pfam:
    UniGene:
    SMR:
    String:
    Uniprot:
     
    FOR
    ELISA Kit for Human Alpha-protein kinase 2
    ELISA Kit for Human Alpha-protein kinase 2
    CLIA Kit for Human Alpha-protein kinase 2
    CLIA Kit for Human Alpha-protein kinase 2
    Polyclonal Antibody for Human Alpha-protein kinase 2
    Polyclonal Antibody for Human Alpha-protein kinase 2
    Monoclonal Antibody for Human Alpha-protein kinase 2
    Monoclonal Antibody for Human Alpha-protein kinase 2
    Protein for Human Alpha-protein kinase 2
    Protein for Human Alpha-protein kinase 2

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA];VARIANTS GLN-719; SER-810; THR-825; ILE-891; LYS-916; VAL-1057; PRO-1174; SER-1449; SER-1551 AND VAL-2157
      tissue: Skeletal muscle.
    2. 3.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 552-1770;VARIANTS GLN-719; SER-810; THR-825; ILE-891; LYS-916; VAL-1057; PRO-1174; SER-1449 AND VAL-2157
      tissue: Heart.
      tissue: Teratocarcinoma.
    3. 4.
      "Alpha-kinases: a new class of protein kinases with a novel catalytic domain."
      Ryazanov A.G. , Pavur K.S. , Dorovkov M.V.
      Curr. Biol.9:R43-R45(1999) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 569-2170;VARIANTS GLN-719; SER-810; THR-825; ILE-891; LYS-916; VAL-1057; PRO-1174 AND SER-1449
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2026 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter